Neonatal alloimmune thrombocytopenia

From WikiMD.org
Jump to navigation Jump to search

Neonatal Alloimmune Thrombocytopenia (NAT) (pronunciation: nee-oh-nay-tal al-oh-im-yoon throm-bo-sigh-toe-pee-nee-uh) is a rare but potentially serious condition that can affect newborns.

Etymology

The term "Neonatal Alloimmune Thrombocytopenia" is derived from several roots. "Neonatal" comes from the Latin neo meaning "new", and natal meaning "birth". "Alloimmune" is derived from the Greek allos meaning "other", and immune referring to the immune system. "Thrombocytopenia" comes from the Greek thrombos meaning "clot", kytos meaning "cell", and penia meaning "deficiency".

Definition

Neonatal Alloimmune Thrombocytopenia is a condition where the pregnant mother's immune system produces antibodies that attack the baby's platelets, leading to a low platelet count (thrombocytopenia) in the baby. This can cause bleeding problems in the baby, both before and after birth.

Related Terms

  • Thrombocytopenia: A condition characterized by abnormally low levels of platelets in the blood.
  • Alloimmunity: An immune response to non-self antigens from members of the same species, which can be a factor in transplant rejection and some autoimmune diseases.
  • Neonatology: A subspecialty of pediatrics that consists of the medical care of newborn infants, especially the ill or premature newborn.
  • Antibody: A blood protein produced in response to and counteracting a specific antigen. Antibodies combine chemically with substances which the body recognizes as alien, such as bacteria, viruses, and foreign substances in the blood.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski